Brief: Prostatype Genomics AB Says Sales In 2022 Are Estimated To Amount To Sek 700,000
07/11/2022 17:04
Nov 7 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* SALES IN 2022 ARE ESTIMATED TO AMOUNT TO SEK 700,000
Source text for Eikon: ID:nWkrc8S5yH
Further company coverage: PROGEN.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants